High-throughput, multiplexed phosphoproteomics with Fe-NTA magnetic beads enrichment and TMTpro 32plex quantification on Orbitrap Tribrid MS

Significance of the topic

Quantitative phosphoproteomics maps dynamic phosphorylation events that regulate cellular signaling and are critical for understanding disease mechanisms, drug response, and biomarker discovery. High-throughput, multiplexed approaches that combine enrichment, deep fractionation, and accurate isobaric labeling expand the number of samples compared in a single experiment while preserving sensitivity for low-abundance phosphopeptides. The workflow summarized here demonstrates a scalable route to profile phosphorylation across multiple cancer cell lines with high specificity and robust relative quantification using TMTpro 32plex reagents combined with Fe-NTA magnetic bead enrichment and Orbitrap Tribrid mass spectrometry.

Goals and study overview

The study aimed to develop and validate a high-throughput multiplexed phosphoproteomics workflow that:

• Enables accurate relative quantification across up to 32 samples in a single experiment using TMTpro 32plex.
• Provides efficient and specific enrichment of phosphopeptides from complex cellular digests using High-Select Fe-NTA magnetic beads.
• Increases phosphoproteome depth through offline high-pH reversed-phase fractionation.
• Is compatible with automated handling and scalable peptide input amounts while retaining high phosphospecificity and identification rates.

Experimental design and sample set

Multiple cancer cell lines (A549, MCF7, Hs578T, LNCaP, HCT116, HepG2) were grown with stimulation conditions (e.g., hIGF-1/hEGF). Lysates were prepared with phosphatase inhibitors, precipitated, digested, and labeled with TMTpro 32plex reagents. Pooled reference channels (TMTpro 126 and 127D) were included to enable inter-subplex normalization. Enrichment, fractionation, LC-MS acquisition, and data processing were then applied to the multiplexed pool to deliver deep phosphoproteome quantification across the cell lines.

Methodology

Sample preparation and enrichment:

• Cell lysis with phosphatase inhibitor (Halt) and acetone precipitation.
• Digestion using EasyPep chemistry and cleanup with mixed-mode SPE and DVB SPE.
• TMTpro 32plex labeling of aliquots and pooling; two pooled channels (126, 127D) used as controls for normalization.
• Phosphopeptide enrichment with High-Select Fe-NTA magnetic beads (optimized bead:sample ratio ~1:50 w/w; operationally effective at 1 µg bead per 50 µg peptide, with recommended conditions achieving high specificity).
• Offline high-pH reversed-phase (HP-RP) fractionation into eight fractions to reduce complexity and increase identification depth.

LC-MS/MS acquisition:

• Thermo Scientific Orbitrap Eclipse Tribrid MS coupled to Vanquish Neo UHPLC.
• 50 cm EASY-Spray C18 column; nanoflow gradient 2–28% ACN with 0.1% formic acid over 120 min at 300 nL/min.
• FT-MS1 at 120,000 resolution (m/z 400–1400); data-dependent acquisition with 3 s cycle and 60 s dynamic exclusion.
• HCD MS2 collected as FT-MS2 with either 90k resolution or TurboTMT 50k mode; normalized collision energy 36–40.

Data analysis:

• Proteome Discoverer 3.3 with SEQUEST HT for database searching against UniProt human.
• Static modifications: carbamidomethylation (C), TMTpro tags on N-termini and lysines (Δm = 304.2071 Da). Dynamic modifications: oxidation (M) and phosphorylation (S,T,Y).
• FDR filtering at 1% using Percolator; reporter ion integration within an 11 ppm window.
• Reporter Ion Control Channel Normalizer used to correct between deuterated and non-deuterated TMTpro sub-plexes; global normalization by total peptide amount and scaling to average abundance per channel.

Instrumental methods used

Key instruments and consumables used in the workflow:

• Orbitrap Eclipse Tribrid mass spectrometer (Thermo Scientific).
• Vanquish Neo UHPLC system (Thermo Scientific).
• EASY-Spray 50 cm C18 column (Thermo Scientific, ES775500PN).
• TMTpro 32plex Label Reagents (Thermo Scientific).
• High-Select Fe-NTA Magnetic Beads kit for phosphopeptide enrichment.
• Pierce High-pH Reversed-phase Peptide Fractionation kit for offline fractionation.
• EasyPep Maxi MS Sample Prep kit, Halt phosphatase inhibitor, and mixed-mode/DVB SPE resins for cleanup.

Main results and discussion

Enrichment performance and specificity:

• High-Select Fe-NTA magnetic beads achieved phosphopeptide specificity ≥90% across a wide peptide input range (25–150 µg); a labeled nocodazole-treated HeLa digest showed ~89.9% phosphospecificity after enrichment.
• Optimal bead-to-sample ratio around 1:50 (w/w) provided efficient recovery and high selectivity, supporting scalable sample handling.

Depth and quantification gains:

• Combining Fe-NTA enrichment with high-pH offline fractionation increased phosphopeptide and protein identifications substantially; high-pH fractionation boosted identifications by ~88% compared to enrichment alone.
• The integrated workflow (TMTpro 32plex + Fe-NTA + HP-RP fractionation) enabled quantification of nearly 5,000 phosphorylated proteins across the multiplexed cancer cell line panel.

Biological findings and reproducibility:

• Cell-line-specific phosphoprotein abundance patterns were observed, consistent with known cancer biology. Selected examples include ALDH1A1 (23 peptides, phosphosite T267), MAOA (6 peptides, S383), RERG (3 peptides, S181/S182/T183), AKAP12 (37 peptides, 18 phosphosites), Vimentin (13 peptides, S56), and IQGAP2 (5 peptides, S16/S685/S1358).
• Fractionation into eight high-pH RP fractions distributed phosphopeptide identifications across fractions, increasing coverage of phosphorylation sites and supporting robust quantification across samples.

Analytical considerations:

• Inclusion of pooled reference channels (126, 127D) allowed correction between TMTpro sub-plexes and improved cross-sample comparability.
• Use of TurboTMT or high-resolution MS2 modes increases reporter ion signal while maintaining PTM localization capacity; MS acquisition settings were tuned for a balance of depth and quantitative accuracy.

Benefits and practical applications

This workflow offers several practical advantages for research and translational projects:

• High multiplexing density (32 channels) reduces batch effects and cost per sample when profiling cohorts or multi-condition experiments.
• Magnetic bead enrichment is rapid, scalable, and compatible with automation for higher throughput.
• High phosphospecificity and offline fractionation provide deep coverage of phosphorylation sites, enabling detection of low-abundance regulatory events relevant to signaling and drug response.
• Robust normalization strategy with pooled reference channels facilitates accurate relative quantification across samples and sub-plexes.

Target use cases include large-scale cancer signaling studies, drug mechanism-of-action profiling, time-course experiments, and multiplexed biomarker discovery.

Future trends and potential applications

Expected developments and opportunities building on this workflow:

• Expansion of multiplexing capacity and improved isotopic tag chemistries to further increase throughput and lower per-sample cost.
• Integration with automated liquid handling for routine large-cohort phosphoproteomics and improved reproducibility.
• Refinements in enrichment chemistries (e.g., metal-ion affinity, mixed-mode strategies) and orthogonal fractionation schemes to increase site localization and coverage.
• Application of data-independent acquisition (DIA) approaches or hybrid DDA/DIA strategies to increase sensitivity and quantitative consistency for PTMs.
• Enhanced software and machine learning tools for improved phosphorylation site localization, cross-run alignment, and biological interpretation at scale.
• Translation toward clinically oriented workflows, including standardized QC metrics and regulatory-compliant sample processing for biomarker validation.

Conclusions

The described workflow—combining TMTpro 32plex isobaric labeling, High-Select Fe-NTA magnetic bead enrichment, offline high-pH fractionation, and Orbitrap Tribrid MS analysis—delivers high phosphopeptide specificity, deep proteome coverage, and accurate relative quantification across many samples. It is well suited for multiplexed studies of cancer signaling biology and other applications that require sensitive detection of phosphorylation changes across multiple conditions or cell types. The approach is scalable, amenable to automation, and benefits from orthogonal fractionation and robust normalization to maximize identification depth and quantitative reliability.

References

• Frost D, Flora A, Foster L, Jensen P, Patel B, Bomgarden R. High-throughput, multiplexed phosphoproteomics with Fe-NTA magnetic beads enrichment and TMTpro 32plex quantification on Orbitrap Tribrid MS. Thermo Fisher Scientific; 2026. Application note.